Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Share-based Compensation (2021 - 2025)

P3 Health Partners (PIII) has disclosed Share-based Compensation for 5 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Share-based Compensation fell 38.15% year-over-year to $1.2 million, compared with a TTM value of $5.2 million through Sep 2025, down 13.4%, and an annual FY2024 reading of $5.8 million, down 3.8% over the prior year.
  • Share-based Compensation was $1.2 million for Q3 2025 at P3 Health Partners, down from $1.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $11.7 million in Q1 2022 and bottomed at $355093.0 in Q3 2021.
  • Average Share-based Compensation over 5 years is $2.1 million, with a median of $1.5 million recorded in 2024.
  • The sharpest move saw Share-based Compensation surged 2443.02% in 2022, then plummeted 91.66% in 2023.
  • Year by year, Share-based Compensation stood at $2.3 million in 2021, then dropped by 5.54% to $2.2 million in 2022, then crashed by 55.45% to $977000.0 in 2023, then decreased by 26.2% to $721000.0 in 2024, then soared by 67.96% to $1.2 million in 2025.
  • Business Quant data shows Share-based Compensation for PIII at $1.2 million in Q3 2025, $1.5 million in Q2 2025, and $1.8 million in Q1 2025.